Depression is a common mental health condition that continues to challenge researchers and clinicians in the quest for effective treatments. Serotonin, a neurotransmitter often associated with mood ...
The United States Anxiety Disorders and Depression Treatment Market is projected to grow from USD 6.17 billion in 2024 to USD ...
Researchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to ...
Activation of the serotonin receptor, 5-HT1A, has been shown to regulate mood and cognition. The receptor is the primary target of buspirone, vilazodone, and gepirone, FDA-approved medications for the ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Evecxia Therapeutics—the first company dedicated to realizing the therapeutic potential of Serotonin Synthesis Amplification to treat central nervous ...
Serotonin in depression is highly relevant in diagnosis, treatment, and drug development. To better study this area, a Chinese team has now developed a fluorescent probe for imaging processes that is ...
Scientists have discovered a protein in the brain called P11 that may explain how drugs like Prozac fight depression -- and why they take so long to work. The finding, published in the current issue ...
New research findings often garner great attention. But when other scientists follow up and fail to replicate the findings? Not so much. In fact, a recent study published in PLOS One indicates that ...
By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 28, 2025 (HealthDay News) — Ketamine might not be effective in treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback